Huntington-kór: vizsgálatok itt: Spanyolország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleStudy to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
- Where
- Barcelona, Madrid
- Életkor
- 25 év and over
- People
- 400 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07378644 · EU 2025-522263-14-00 - 3. fázisTaking peoplePridopidine Phase 3 Study in Huntington's Disease
- Where
- Barakaldo, Barcelona, Madrid, Oviedo, Sevilla
- Életkor
- 23 év to 65 év
- People
- 400 worldwide
- Run by
- Prilenia
See details and how to joinNCT07609108 · EU 2026-526093-16-00 - No phaseNot yet taking people in SpanyolországCreatine and Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation Plus Home-Based Exercise for Sarcopenia in Huntington's Disease
- Where
- Burgos
- Életkor
- 18 év and over
- People
- 88
- Run by
- Universidad de Burgos
See details and how to joinNCT07902206 - 3. fázisTaking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Badajoz, Barakaldo, Barcelona, Burgos, L'hospitalet De Llobregat, Madrid, Málaga, Palma, Sevilla, Valencia
- Életkor
- 21 év to 70 év
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - No phaseTaking peopleHDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- Where
- Barcelona, Bilbao, Madrid
- Életkor
- 11 év to 75 év
- People
- 2500 worldwide
- Run by
- University College, London
See details and how to joinNCT02855476 - 2. fázisTaking peopleTrial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease
- Where
- Donostia, Sevilla, Hospital Ramón y Cajal (Madrid, SPAIN)
- Életkor
- 18 év and over
- People
- 24
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT04478734 · EU 2023-508637-14-00 - 3. fázisTaking peopleRandomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progression in Huntington's disease patients.
- Where
- Albacete, Alicante, Barcelona, Burgos, Elche, Madrid, Oviedo, Palma, Valencia
- Életkor
- 18 év and over
- People
- 60
- Run by
- IIS La Fe
See details and how to join2024-518875-73-00 · EU 2024-518875-73-00 - No phaseTaking peopleEnroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Where
- Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- CHDI Foundation, Inc.
See details and how to joinNCT01574053